文献速递冠心病

药物涂层球囊对比支架治疗 Medina 0.0.1 冠状动脉分叉病变的一年临床与血管造影结局

Drug‐Coated Balloon Versus Stenting for Medina 0.0.1 Coronary Bifurcation Lesions: One‐Year Clinical and Angiographic Outcomes of a Leave‐Nothing‐Behind Strategy
RSS 订阅 · Catheterization and Cardiovascular Interventions · 2026-09-23

该前瞻性观察性队列研究纳入 161 例症状性缺血性心脏病合并 de novo Medina 0.0.1 分叉病变患者,按术者判断分为支架组(80 例)与药物涂层球囊组(81 例)。1 年随访显示药物涂层球囊组晚期管腔丢失、二元再狭窄、靶血管血运重建及主要不良心脏事件均显著低于支架组。但治疗分配主要取决于预扩张反应,研究未能确立药物涂层球囊优于药物洗脱支架。

要点

  • 药物涂层球囊组 1 年晚期管腔丢失显著低于支架组(0.16±0.12mm 对 0.48±0.22mm,p<0.001)。
  • 药物涂层球囊组靶血管血运重建率为 4.9%,支架组为 15.0%,NNT 为 10。
  • 治疗选择受预扩张反应影响,结果不能证明药物涂层球囊优于药物洗脱支架。

核心结论

  • 在 Medina 0.0.1 分叉病变中,成功病变准备后的药物涂层球囊策略 1 年血管造影与临床结局优于支架策略,包括更低的晚期管腔丢失、再狭窄、再次血运重建及主要不良心脏事件。
  • 主要不良心脏事件的降低主要由靶血管血运重建事件减少驱动。

研究设计与样本

  • 前瞻性、观察性队列研究,纳入 161 例症状性缺血性心脏病合并 de novo Medina 0.0.1 分叉病变患者。
  • 患者按术者判断分为支架组(Group A,n=80)与药物涂层球囊组(Group B,n=81)。
  • 主要终点为 1 年随访的绝对晚期管腔丢失、二元再狭窄、靶血管血运重建及五要点主要不良心脏事件复合终点。

主要发现

  • 药物涂层球囊组平均晚期管腔丢失显著低于支架组(0.16±0.12mm 对 0.48±0.22mm;p<0.001)。
  • 药物涂层球囊组二元再狭窄率显著低于支架组(7.4% 对 21.3%;RR 0.35,95% CI 0.15–0.82;p=0.014;ARR 13.9%;NNT 7)。
  • 药物涂层球囊组靶血管血运重建率显著降低(4.9% 对 15.0%;RR 0.33,95% CI 0.11–0.96;p=0.038;ARR 10.1%;NNT 10)。
  • 药物涂层球囊组主要不良心脏事件发生率显著较低(7.4% 对 18.7%;RR 0.40,95% CI 0.17–0.93;p=0.043;ARR 11.3%;NNT 9),主要归因于靶血管血运重建减少。

关键数值与推荐

  • 药物涂层球囊组晚期管腔丢失为 0.16±0.12mm,支架组为 0.48±0.22mm,p<0.001。
  • 二元再狭窄:药物涂层球囊组 7.4% 对支架组 21.3%;RR 0.35,95% CI 0.15–0.82;p=0.014。
  • 靶血管血运重建:药物涂层球囊组 4.9% 对支架组 15.0%;RR 0.33,95% CI 0.11–0.96;p=0.038。
  • 主要不良心脏事件:药物涂层球囊组 7.4% 对支架组 18.7%;RR 0.40,95% CI 0.17–0.93;p=0.043。

临床怎么用

  • 对于 Medina 0.0.1 分叉病变,成功的病变准备后选用药物涂层球囊策略可作为一种「leave-nothing-behind」的治疗选择。
  • 治疗决策需结合预扩张反应,不能仅依据本研究结果判定药物涂层球囊优于药物洗脱支架。

局限性

  • 治疗分配主要由预扩张反应决定,并非随机化分配,结果不能确立药物涂层球囊对药物洗脱支架的优效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Background The optimal treatment for isolated side-branch coronary bifurcation lesions (Medina 0.0.1) remains debated. Drug-coated balloons (DCB) offer a “leave-nothing-behind” alternative to drug-eluting stents (DES), but comparative data for this specific lesion subset is limited. Aims This study aimed to compare the 1-year clinical and angiographic outcomes of a DCB strategy versus a contemporary stenting strategy for Medina 0.0.1 lesions. Methods This prospective, observational cohort study enrolled 161 patients with symptomatic ischemic heart disease and de novo Medina 0.0.1 bifurcation lesions. Patients were allocated to either a stenting strategy (Group A, n = 80) or a DCB strategy (Group B, n = 81) based on operator judgment. The primary endpoints were absolute late lumen loss (LLL), binary restenosis, target vessel revascularization (TVR), and a five-point composite of major adverse cardiac events (MACE) at 1-year follow-up. Results Baseline characteristics were comparable between the two groups. At 1 year, the mean late lumen loss (LLL) was significantly lower in the DCB group compared with the stenting group (0.16 ± 0.12 mm vs. 0.48 ± 0.22 mm; p < 0.001). The DCB group demonstrated a significantly lower rate of binary restenosis compared with the stenting group (7.4% vs. 21.3%; RR 0.35, 95% CI 0.15–0.82; p = 0.014; ARR 13.9%; NNT 7). TVR was significantly reduced in the DCB group (4.9% vs. 15.0%; RR 0.33, 95% CI 0.11–0.96; p = 0.038; ARR 10.1%; NNT 10). The incidence of MACE was also markedly lower in the DCB group (7.4% vs. 18.7%; RR 0.40, 95% CI 0.17–0.93; p = 0.043; ARR 11.3%; NNT 9), primarily attributed to the reduction in TVR. Conclusion In patients with isolated Medina 0.0.1 bifurcation lesions, a DCB strategy following successful lesion preparation was associated with favorable angiographic and clinical outcomes at 1 year compared with a stenting strategy, including lower late lumen loss, reduced angiographic restenosis and repeat revascularization, and a lower incidence of MACE, driven primarily by fewer repeat revascularization events. However, because treatment allocation was largely determined by predilation response, these findings did not establish the comparative superiority of DCB over DES.

来源:Catheterization and Cardiovascular Interventions,查看原文。版权归原作者所有。

引用

  1. Catheterization and Cardiovascular Interventions:Drug‐Coated Balloon Versus Stenting for Medina 0.0.1 Coronary Bifurcation Lesions: One‐Year Clinical and Angiographic Outcomes of a Leave‐Nothing‐Behind Strategy

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。